Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ABBVIE

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 48
  • 0 comments

FDA approve CYCLOSPORINE

Comment Full text

CARNEGIE

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 40
  • 0 comments

FDA approve BALSALAZIDE DISODIUM

Comment Full text

LARKEN LABS

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 52
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text

ABBVIE

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 42
  • 0 comments

FDA approve CYCLOSPORINE

Comment Full text

DR REDDYS

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 49
  • 0 comments

FDA approve LEVOCETIRIZINE DIHYDROCHLORIDE

Comment Full text

TORRENT

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 37
  • 0 comments

FDA approve MONTELUKAST SODIUM

Comment Full text

HIKMA

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 51
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

TORRENT PHARMS LTD

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 40
  • 0 comments

FDA approve MONTELUKAST SODIUM

Comment Full text

QILU PHARM HAINAN

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 60
  • 0 comments

FDA approve MICAFUNGIN SODIUM

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 61
  • 0 comments

FDA approve TROSPIUM CHLORIDE

Comment Full text
  • Previous
  • 159
  • 160
  • 161
  • 162
  • 163
  • Next

Search

News categories

  • Technical Exchange News(10597)
  • Event(2007)
  • SEC News(184706)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122354)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin